Altinoz, M. A. Et Al. 2019. Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.46, no.8 , 694-704.

Altinoz, M. A., ÖZPINAR, A., Ozpinar, A., Hacker, E., & Elmaci, I., (2019). Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.46, no.8, 694-704.

Altinoz, Meric Et Al. "Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?," CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.46, no.8, 694-704, 2019

Altinoz, Meric A. Et Al. "Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.46, no.8, pp.694-704, 2019

Altinoz, M. A. Et Al. (2019) . "Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.46, no.8, pp.694-704.

@article{article, author={Meric A. Altinoz Et Al. }, title={Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?}, journal={CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY}, year=2019, pages={694-704} }